Transcept Pharmaceuticals Inc financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2013-03-31 3 months ending 2012-12-31 3 months ending 2012-09-30 3 months ending 2012-06-30 3 months ending 2012-03-31
Revenue -5.83 -1.34 10.44 0.49 0.00
Other Revenue, Total - - - - -
Total Revenue -5.83 -1.34 10.44 0.49 0.00
Cost of Revenue, Total - - - - -
Gross Profit -5.83 -1.34 10.44 0.49 0.00
Selling/General/Admin. Expenses, Total 2.80 2.27 2.48 2.73 2.78
Research & Development 1.84 2.92 3.06 2.86 2.36
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) - - - - -
Other Operating Expenses, Total - - - - -
Total Operating Expense 4.64 5.18 5.54 5.59 5.14
Operating Income -10.47 -6.52 4.90 -5.10 -5.14
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net -0.03 -0.04 -0.04 -0.04 -0.04
Income Before Tax -10.50 -6.55 4.86 -5.14 -5.18
Income After Tax -10.50 -6.55 4.86 -5.14 -5.18
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items -10.50 -6.55 4.86 -5.14 -5.18
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income -10.50 -6.55 4.86 -5.14 -5.18
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items -10.50 -6.55 4.86 -5.14 -5.18
Income Available to Common Incl. Extra Items -10.50 -6.55 4.86 -5.14 -5.18
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment 0.00 0.00 0.00 0.00 0.00
Diluted Weighted Average Shares 18.70 18.63 19.23 17.05 13.93
Diluted EPS Excluding Extraordinary Items -0.56 -0.35 0.25 -0.30 -0.37
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS -0.55 -0.35 0.25 -0.30 -0.37